← Eichor
Study identifier: NCT06543667 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye

Condition: Dry Eye Syndromes  ·  Sponsor: Iran University of Medical Sciences

PhasePhase 1
Planned participants30
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The purpose of this study is to determine the safety and efficacy of Limbal Stem Cells derived Exosomes (LSC-Exo) in alleviation of dry eye symptoms

This description comes directly from the study's public registry record.

Talk to the study team

Hossein Aghaei, MD  ·  +982155661188  ·  draghaei.h@gmail.com

Alireza Shoae-Hassani  ·  +989121454878  ·  cell.therapy@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Moheb Kowsar HospitalTehran, IranRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06543667